Macclesfield
United Kingdom
The University of Manchester - Cancer Research UK Manchester Institute
Polycystic ovary syndrome, obesity, type 2 diabetes, cardiovascular disease, metabolic disease, metabolic dysfunction associated steatotic liver disease, hormone-dependent cancer
castration-resistant prostate cancer, targeted therapy, MAPK signaling, LY6D luminal cancer cells, tumor initiation